Elevated MTA3 levels in these aggressive variants are significantly associated with advanced surgical stage, lymph node metastasis, lymphovascular space invasion, and reduced progression-free and overall survival, establishing MTA3 as an independent prognostic factor (58, 59). This evidence concerns the gene MTA3 and metastatic malignant neoplasm in the lymph nodes.